| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8780841 | Gynecologic Oncology | 2017 | 8 Pages |
Abstract
GEN-1 in combination with PLD has encouraging clinical benefit and biological activity in recurrent or persistent EOC and warrants further investigation with escalating doses of GEN-1.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Premal H. Thaker, William E. Brady, Heather A. Lankes, Kunle Odunsi, William H. Bradley, Kathleen N. Moore, Carolyn Y. Muller, Khursheed Anwer, Russell J. Schilder, Ronald D. Alvarez, Paula M. Fracasso,